Form 4: Strobeck Matthew reports purchase transactions in QDEL

Rhea-AI Filing Summary

Strobeck Matthew reported open-market purchase transactions in a Form 4 filing for QDEL. The filing lists transactions totaling 10,000 shares at a weighted average price of $23.96 per share. Following the reported transactions, holdings were 27,775 shares.

Insider Trade Summary

Net Buyer: 10,000 shares ($239,586)

Net Buy 3 txns

Insider Strobeck Matthew

Role Director

Bought 10,000 shs ($240K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	10,000	$23.9586	$240K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 27,775 shares (Direct); Common Stock — 16,630 shares (Indirect, UGMA Account)

Footnotes (1)

1. The weighted average purchase price of these transactions was $23.9586 per share, with a range of $23.7600 to $23.9999 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price. The Reporting Person is custodian under the Uniform Gift to Minor Act of 16,630 shares held by four of the Reporting Person's children. The Reporting Person disclaims beneficial ownership of these shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. The Reporting Person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC in his capacity as the Managing Partner of such entity. The Reporting Person disclaims beneficial ownership of the shares held by Birchview Fund, LLC except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Strobeck Matthew

(Last) (First) (Middle)

9975 SUMMERS RIDGE ROAD

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		P		10,000	A	$23.9586(1)	27,775	D
Common Stock								16,630	I	UGMA Account(2)
Common Stock								38,145	I	Birchview(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The weighted average purchase price of these transactions was $23.9586 per share, with a range of $23.7600 to $23.9999 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.

2. The Reporting Person is custodian under the Uniform Gift to Minor Act of 16,630 shares held by four of the Reporting Person's children. The Reporting Person disclaims beneficial ownership of these shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

3. The Reporting Person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC in his capacity as the Managing Partner of such entity. The Reporting Person disclaims beneficial ownership of the shares held by Birchview Fund, LLC except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Remarks:

	/s/ Phillip S. Askim, attorney-in-fact for Matthew W. Strobeck	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did QuidelOrtho (QDEL) report for Matthew W. Strobeck?

QuidelOrtho reported that director Matthew W. Strobeck bought 10,000 shares of common stock. The open-market purchase occurred on February 13, 2026 at a weighted average price of $23.9586 per share, increasing his directly held stake to 27,775 shares.

At what price did the QuidelOrtho (QDEL) director buy his shares?

Matthew W. Strobeck’s 10,000-share purchase had a weighted average price of $23.9586 per share. Individual trades were executed in a range between $23.7600 and $23.9999 per share, and he has offered to provide detailed price breakdowns upon request.

How many QuidelOrtho (QDEL) shares does Matthew W. Strobeck now hold directly and indirectly?

After the reported transaction, Matthew W. Strobeck directly holds 27,775 QuidelOrtho common shares. The filing also lists 16,630 shares in UGMA accounts for his children and 38,145 shares held by Birchview Fund, LLC, with Strobeck disclaiming full beneficial ownership of these indirect positions.

What are the UGMA account holdings related to QuidelOrtho (QDEL) in this Form 4?

The Form 4 states that 16,630 QuidelOrtho shares are held in Uniform Gift to Minor Act accounts for four of Matthew W. Strobeck’s children. He is custodian for these accounts and expressly disclaims beneficial ownership of these shares for Section 16 and other purposes.

How is Birchview Fund, LLC related to the QuidelOrtho (QDEL) director’s holdings?

Birchview Fund, LLC holds 38,145 QuidelOrtho shares, and Matthew W. Strobeck has sole voting and dispositive power as its Managing Partner. He disclaims beneficial ownership of these shares except to the extent of his pecuniary interest, according to the filing’s footnote.

What role does Matthew W. Strobeck hold at QuidelOrtho (QDEL)?

The filing identifies Matthew W. Strobeck as a director of QuidelOrtho Corp. He is not listed as an officer or 10% owner in this report, and the Form 4 reflects his status as a single reporting person for the disclosed equity holdings and transaction.